Abstract
Cell migration is essential throughout the life of multicellular organisms, and largely depends on the spatial and temporal regulation of cytoskeletal dynamics, cell adhesion and signal transduction. Interestingly, Estrogen-related receptor alpha (ERRα) has been identified as a major regulator of cell migration in both physiological and pathological conditions. ERRα is an orphan member of the nuclear hormone receptor superfamily of transcription factors and displays many biological functions. ERRα is a global regulator of energy metabolism, and it is also highly involved in bone homeostasis, development, differentiation, immunity and cancer progression. Importantly, in some instances, the regulation of these biological processes relies on the ability to orchestrate cell movements. Therefore, this review describes how ERRα-mediated cell migration contributes not only to tissue homeostasis but also to tumorigenesis and metastasis, and highlights the molecular and cellular mechanisms by which ERRα finely controls the cell migratory potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mayor R, Etienne-Manneville S. The front and rear of collective cell migration. Nat Rev Mol Cell Biol. 2016;17:97–109.
Bravo-Cordero JJ, Hodgson L, Condeelis J. Directed cell invasion and migration during metastasis. Curr Opin Cell Biol. 2012;24:277–83.
De Pascalis C, Etienne-Manneville S. Single and collective cell migration: the mechanics of adhesions. Mol Biol Cell. 2017;28:1833–46.
SenGupta S, Parent CA, Bear JE. The principles of directed cell migration. Nat Rev Mol Cell Biol. 2021;22:529–47.
Gardel ML, Schneider IC, Aratyn-Schaus Y, Waterman CM. Mechanical integration of actin and adhesion dynamics in cell migration. Annu Rev Cell Dev Biol. 2010;26:315–33.
Lawson CD, Ridley AJ. Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 2018;217:447–57.
Seetharaman S, Etienne-Manneville S. Cytoskeletal crosstalk in cell migration. Trends Cell Biol. 2020;30:720–35.
Villena JA, Kralli A. ERRα: a metabolic function for the oldest orphan. Trends Endocrinol Metab. 2008;19:269–76.
Tam IS, Giguère V. There and back again: the journey of the estrogen-related receptors in the cancer realm. J Steroid Biochem Mol Biol. 2016;157:13–19.
Ranhotra HS. The estrogen-related receptors in metabolism and cancer: newer insights. J Receptors Signal Transduct. 2018;38:95–100.
Giguère V, Yang N, Segui P, Evans RM. Identification of a new class of steroid hormone receptors. Nature. 1988;331:91–94.
Crevet L, Vanacker J-M. Regulation of the expression of the estrogen related receptors (ERRs). Cell Mol Life Sci. 2020;77:4573–9.
Tripathi M, Yen PM, Singh BK. Estrogen-related receptor alpha: an under-appreciated potential target for the treatment of metabolic diseases. IJMS. 2020;21:1645.
Sever R, Glass CK. Signaling by nuclear receptors. Cold Spring Harb Perspect Biol. 2013;5:a016709–a016709.
Huss JM, Garbacz WG, Xie W. Constitutive activities of estrogen-related receptors: Transcriptional regulation of metabolism by the ERR pathways in health and disease. Biochim. Biophys. Acta (BBA) Mol Basis Dis. 2015;1852:1912–27.
Sladek R, Bader JA, Giguère V. The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol. 1997;17:5400–9.
Vanacker J-M. Transcriptional activities of the orphan nuclear receptor ERR (Estrogen Receptor-Related Receptor-). Mol Endocrinol. 1999;13:764–73.
Mohideen-Abdul K, Tazibt K, Bourguet M, Hazemann I, Lebars I, Takacs M, et al. Importance of the sequence-directed DNA shape for specific binding site recognition by the estrogen-related receptor. Front Endocrinol. 2017;8:140.
Patel AKM, Vilela P, Shaik TB, McEwen AG, Hazemann I, Brillet K, et al. Asymmetric dimerization in a transcription factor superfamily is promoted by allosteric interactions with DNA. Nucleic Acids Res. 2023;51:8864–79.
Kallen J, Schlaeppi J-M, Bitsch F, Filipuzzi I, Schilb A, Riou V, et al. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor α (ERRα). J Biol Chem. 2004;279:49330–7.
Bianco S, Sailland J, Vanacker J-M. ERRs and cancers: Effects on metabolism and on proliferation and migration capacities. J Steroid Biochem Mol Biol. 2012;130:180–5.
Deblois G, Giguère V. Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochim Biophys Acta (BBA) Mol Basis Dis. 2011;1812:1032–40.
Ariazi EA, Kraus RJ, Farrell ML, Jordan VC, Mertz JE. Estrogen-related receptor 1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Mol Cancer Res. 2007;5:71–85.
Barry JB, Giguere V. Epidermal growth factor–induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor A. Cancer Res. 2005;65:6120–9.
Tremblay AM, Wilson BJ, Yang X-J, Giguère V. Phosphorylation-dependent sumoylation regulates estrogen-related Receptor-α and -γ transcriptional activity through a synergy control motif. Mol Endocrinol. 2008;22:570–84.
Vu EH, Kraus RJ, Mertz JE. Phosphorylation-dependent sumoylation of estrogen-related receptor α1. Biochemistry. 2007;46:9795–804.
Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguère V. An acetylation switch modulates the transcriptional activity of estrogen-related receptor α. Mol Endocrinol. 2010;24:1349–58.
Audet-walsh É, Giguére V. The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases. Acta Pharmacol Sin. 2015;36:51–61.
Alaynick WA, Kondo RP, Xie W, He W, Dufour CR, Downes M, et al. ERRγ directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 2007;6:13–24.
Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, et al. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRα and γ. Cell Metab. 2007;5:345–56.
Carnesecchi J, Vanacker J-M. Estrogen-related receptors and the control of bone cell fate. Mol Cell Endocrinol. 2016;432:37–43.
Guo X, Yue L, Li M, Dai A, Sun J, Fang L, et al. Nuclear receptor estrogen-related receptor gamma suppresses colorectal cancer aggressiveness by regulating Wnt/β-catenin signaling. Carcinogenesis. 2022;43:865–73.
Gulwani D, Upadhyay P, Goel R, Sarangthem V, Debraj Singh T. Unfolding of imminent bio-signatures in the prognosis of thyroid cancer; the emergence of estrogen related receptor gamma (ERRγ) as a hurricane. Asian Pac J Cancer Prev. 2023;24:375–87.
Tiraby C, Hazen BC, Gantner ML, Kralli A. Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth. Cancer Res. 2011;71:2518–28.
Kang M-H, Choi H, Oshima M, Cheong J-H, Kim S, Lee JH, et al. Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer. Nat Commun. 2018;9:1920.
Riggins RB, Lan JP-J, Zhu Y, Klimach U, Zwart A, Cavalli LR, et al. ERRγ mediates Tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res. 2008;68:8908–17.
Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, et al. Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer. J Steroid Biochem Mol Biol. 2011;123:1–7.
Heckler MM, Thakor H, Schafer CC, Riggins RB. ERK/MAPK regulates ERRγ expression, transcriptional activity, and receptor-mediated Tamoxifen resistance in ER+ breast cancer. FEBS J. 2014;281:2431–42.
Kim J-H, Choi Y-K, Byun J-K, Kim M-K, Kang YN, Kim SH, et al. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27. Exp Mol Med. 2016;48:e213–e213.
Hua T, Wang X, Chi S, Liu Y, Feng D, Zhao Y, et al. Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4. Oncol Rep. 2018;40:823–32.
Zhou W, Liu Z, Wu J, Liu J, Hyder SM, Antoniou E, et al. Identification and characterization of two novel splicing isoforms of human estrogen-related receptor β. J Clin Endocrinol Metab. 2006;91:569–79.
Tiek DM, Khatib SA, Trepicchio CJ, Heckler MM, Divekar SD, Sarkaria JN, et al. Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma. FASEB J. 2019;33:13476–91.
Heckler MM, Zeleke TZ, Divekar SD, Fernandez AI, Tiek DM, Woodrick J, et al. Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer. Oncotarget. 2016;7:47201–20.
Ranhotra HS. Estrogen-related receptor alpha in select host functions and cancer: new frontiers. Mol Cell Biochem. 2022;477:1349–59.
Huss JM, Kopp RP, Kelly DP. Peroxisome Proliferator-activated Receptor Coactivator-1α (PGC-1α) Coactivates the Cardiac-enriched Nuclear Receptors Estrogen-related Receptor-α and -γ. J Biol Chem. 2002;277:40265–74.
Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A. The Transcriptional Coactivator PGC-1 Regulates the Expression and Activity of the Orphan Nuclear Receptor Estrogen-Related Receptor α (ERRα). J Biol Chem. 2003;278:9013–8.
Deblois G, Giguère V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat Rev Cancer. 2013;13:27–36.
Vanacker J-M, Bonnelye E, Delmarre C, Laudet V. Activation of the thyroid hormone receptor α gene promoter by the orphan nuclear receptor ERRα. Oncogene. 1998;17:2429–35.
Singh BK, Sinha RA, Tripathi M, Mendoza A, Ohba K, Sy JAC, et al. Thyroid hormone receptor and ERRα coordinately regulate mitochondrial fission, mitophagy, biogenesis, and function. Sci Signal. 2018;11:eaam5855.
Flamini MI, Uzair ID, Pennacchio GE, Neira FJ, Mondaca JM, Cuello-Carrión FD, et al. Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases. Horm Cancer. 2017;8:16–27.
Uzair ID, Conte Grand J, Flamini MI, Sanchez AM. Molecular actions of thyroid hormone on breast cancer cell migration and invasion via cortactin/N-WASP. Front Endocrinol. 2019;10:139.
Bonnelye E, Vanacker JM, Spruyt N, Alric S, Fournier B, Desbiens X, et al. Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development. Mech Dev. 1997;65:71–85.
Huss JM, Torra IP, Staels B, Giguère V, Kelly DP. Estrogen-related receptor α directs peroxisome proliferator-activated receptor α signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol. 2004;24:9079–91.
Murray J, Huss JM. Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway. Am J Physiol Cell Physiol. 2011;301:C630–C645.
Shao D, Liu Y, Liu X, Zhu L, Cui Y, Cui A, et al. PGC-1β-Regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERRα. Mitochondrion. 2010;10:516–27.
Wei W, Schwaid AG, Wang X, Wang X, Chen S, Chu Q, et al. Ligand activation of ERRα by cholesterol mediates statin and bisphosphonate effects. Cell Metab. 2016;23:479–91.
LaBarge S, McDonald M, Smith-Powell L, Auwerx J, Huss JM. Estrogen-related receptor-α (ERRα) deficiency in skeletal muscle impairs regeneration in response to injury. FASEB J. 2014;28:1082–97.
Delhon I, Gutzwiller S, Morvan F, Rangwala S, Wyder L, Evans G, et al. Absence of estrogen receptor-related-α increases osteoblastic differentiation and cancellous bone mineral density. Endocrinology. 2009;150:4463–72.
Teyssier C, Gallet M, Rabier B, Monfoulet L, Dine J, Macari C, et al. Absence of ERRα in female mice confers resistance to bone loss induced by age or estrogen-deficiency. PLoS ONE. 2009;4:e7942.
Gallet M, Saïdi S, Haÿ E, Photsavang J, Marty C, Sailland J, et al. Repression of osteoblast maturation by ERRα accounts for bone loss induced by estrogen deficiency. PLoS ONE. 2013;8:e54837.
Bonnelye E, Zirngibl RA, Jurdic P, Aubin JE. The orphan nuclear estrogen receptor-related receptor-α regulates cartilage formation in vitro: implication of Sox9. Endocrinology. 2007;148:1195–205.
Rajalin A-M, Pollock H, Aarnisalo P. ERRα regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 2010;396:477–82.
Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human. Breast Cancer. 2002;62:6510–8.
Suzuki T, Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H, et al. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Res. 2004;64:4670–6.
Cavallini A, Notarnicola M, Giannini R, Montemurro S, Lorusso D, Visconti A, et al. Oestrogen receptor-related receptor alpha (ERRα) and oestrogen receptors (ERα and ERβ) exhibit different gene expression in human colorectal tumour progression. Eur J Cancer. 2005;41:1487–94.
Sun P, Sehouli J, Denkert C, Mustea A, Könsgen D, Koch I, et al. Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells. J Mol Med. 2005;83:457–67.
Cheung CP, Yu S, Wong KB, Chan LW, Lai FMM, Wang X, et al. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. J Clin Endocrinol Metab. 2005;90:1830–44.
Fujimura T, Takahashi S, Urano T, Kumagai J, Ogushi T, Horie‐Inoue K, et al. Increased expression of estrogen-related receptor α (ERRα) is a negative prognostic predictor in human prostate cancer. Int J Cancer. 2007;120:2325–30.
Fujimoto J, Alam SM, Jahan I, Sato E, Sakaguchi H, Tamaya T. Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers. J Steroid Biochem Mol Biol. 2007;104:301–4.
Fujimoto J, Sato E. Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers. J Steroid Biochem Mol Biol. 2009;116:71–75.
Tiwari A, Swamy S, Gopinath KS, Kumar A. Genomic amplification upregulates estrogen-related receptor alpha and its depletion inhibits oral squamous cell carcinoma tumors in vivo. Sci Rep. 2015;5:17621.
Li P, Wang J, Wu D, Ren X, Wu W, Zuo R, et al. ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes. Cancer Manag Res. 2019;11:8111–23.
Liu S-L, Wu X-S, Li F-N, Yao W-Y, Wu Z-Y, Dong P, et al. ERRα promotes pancreatic cancer progression by enhancing the transcription of PAI1 and activating the MEK/ERK pathway. Am J Cancer Res. 2020;10:3622–43.
Bernatchez G, Giroux V, Lassalle T, Carpentier AC, Rivard N, Carrier JC. ERRα metabolic nuclear receptor controls growth of colon cancer cells. Carcinogenesis. 2013;34:2253–61.
Bianco S, Lanvin O, Tribollet V, Macari C, North S, Vanacker J-M. Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem. 2009;284:23286–92.
Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y, et al. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells. PLoS ONE. 2012;7:e39102.
Mukherjee T, Malik P, Hoidal J. The emerging role of estrogen related receptorα in complications of non‑small cell lung cancers (Review). Oncol Lett. 2021;21:258.
Stein RA, Gaillard S, McDonnell DP. Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells. J Steroid Biochem Mol Biol. 2009;114:106–12.
Zhang K, Lu J, Mori T, Smith-Powell L, Synold TW, Chen S, et al. Baicalin increases VEGF expression and angiogenesis by activating the ERR{alpha}/PGC-1{alpha} pathway. Cardiovasc Res. 2011;89:426–35.
Zou C, Yu S, Xu Z, Wu D, Ng C-F, Yao X, et al. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. J Pathol. 2014;233:61–73.
Ao A, Wang H, Kamarajugadda S, Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA. 2008;105:7821–6.
Tennessen JM, Baker KD, Lam G, Evans J, Thummel CS. The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth. Cell Metab. 2011;13:139–48.
Cai Q, Lin T, Kamarajugadda S, Lu J. Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene. 2013;32:2079–86.
Sailland J, Tribollet V, Forcet C, Billon C, Barenton B, Carnesecchi J, et al. Estrogen-related receptor α decreases RHOA stability to induce orientated cell migration. Proc Natl Acad Sci USA. 2014;111:15108–13.
Carnesecchi J, Forcet C, Zhang L, Tribollet V, Barenton B, Boudra R, et al. ERRα induces H3K9 demethylation by LSD1 to promote cell invasion. Proc Natl Acad Sci USA. 2017;114:3909–14.
Zhang L, Carnesecchi J, Cerutti C, Tribollet V, Périan S, Forcet C, et al. LSD1-ERRα complex requires NRF1 to positively regulate transcription and cell invasion. Sci Rep. 2018;8:10041.
Weng S, Wallingford JB. May the force be with you. eLife. 2018;7:e36662.
Bardet P-L, Horard B, Laudet V, Vanacker J-M. The ERRα orphan nuclear receptor controls morphogenetic movements during zebrafish gastrulation. Dev Biol. 2005;281:102–11.
Ulrich F, Concha ML, Heid PJ, Voss E, Witzel S, Roehl H, et al. Slb/Wnt11 controls hypoblast cell migration and morphogenesis at the onset of zebrafish gastrulation. Development. 2003;130:5375–84.
Dwyer MA, Joseph J, Wade HE, Eaton ML, Kunder RS, Kazmin D, et al. WNT11 expression is induced by ERRα and β-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res. 2010;70:9298–308.
Bonnelye E, Saltel F, Chabadel A, Zirngibl RA, Aubin JE, Jurdic P. Involvement of the orphan nuclear estrogen receptor-related receptor α in osteoclast adhesion and transmigration. J Mol Endocrinol. 2010;45:365–77.
Likhite N, Yadav V, Milliman EJ, Sopariwala DH, Lorca S, Narayana NP, et al. Loss of estrogen-related receptor alpha facilitates angiogenesis in endothelial Cells. Mol Cell Biol. 2019;39:e00411–18.
Arany Z, Foo S-Y, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature. 2008;451:1008–12.
Fradet A, Sorel H, Bouazza L, Goehrig D, Depalle B, Bellahcene A, et al. Dual function of ERR in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res. 2011;71:5728–38.
Zhang L-D, Chen L, Zhang M, Qi H-J, Chen L, Chen H-F, et al. Downregulation of ERRα inhibits angiogenesis in human umbilical vein endothelial cells through regulating VEGF production and PI3K/Akt/STAT3 signaling pathway. Eur J Pharmacol. 2015;769:167–76.
Benslimane-Ahmim Z, Pereira J, Lokajczyk A, Dizier B, Galy-Fauroux I, Fischer A-M, et al. Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularization. Cancer Lett. 2017;395:11–19.
Sumi D, Ignarro LJ. Estrogen-related receptor 1 up-regulates endothelial nitric oxide synthase expression. Proc Natl Acad Sci USA. 2003;100:14451–6.
Xia W, Yin J, Zhang S, Guo C, Li Y, Zhang Y, et al. Parkin modulates ERRα/eNOS signaling pathway in endothelial cells. Cell Physiol Biochem. 2018;49:2022–34.
Hu W, Huang Y. Targeting the platelet-derived growth factor signalling in cardiovascular disease. Clin Exp Pharmacol Physiol. 2015;42:1221–4.
Li Q, Zhu L, Zhang L, Chen H, Zhu Y, Du Y, et al. Inhibition of estrogen related receptor α attenuates vascular smooth muscle cell proliferation and migration by regulating RhoA/p27 Kip1 and β-Catenin/Wnt4 signaling pathway. Eur J Pharmacol. 2017;799:188–95.
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.
Huang J, Guan B, Yin L, Liu F, Hu B, Zheng Q, et al. Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells. J Huazhong Univ Sci Technol [Med Sci]. 2014;34:875–81.
Wu Y-M, Chen Z-J, Liu H, Wei W-D, Lu L-L, Yang X-L, et al. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Oncotarget. 2015;6:25588–601.
Chen H, Pan J, Zhang L, Chen L, Qi H, Zhong M, et al. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways. Eur J Pharmacol. 2018;825:133–42.
Yoriki K, Mori T, Kokabu T, Matsushima H, Umemura S, Tarumi Y, et al. Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer. Sci Rep. 2019;9:6697.
Wang L, Yang M, Guo X, Yang Z, Liu S, Ji Y, et al. Estrogen‐related receptor‐α promotes gallbladder cancer development by enhancing the transcription of Nectin‐4. Cancer Sci. 2020;111:1514–27.
Mao X, Lei H, Yi T, Su P, Tang S, Tong Y, et al. Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression. J Exp Clin Cancer Res. 2022;41:28.
Li F-N, Zhang Q-Y, Li O, Liu S-L, Yang Z-Y, Pan L-J, et al. ESRRA promotes gastric cancer development by regulating the CDC25C/CDK1/CyclinB1 pathway via DSN1. Int J Biol Sci. 2021;17:1909–24.
Lam SS, Mak AS, Yam JW, Cheung AN, Ngan HY, Wong AS. Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer Cells. Mol Ther. 2014;22:743–51.
Ma J-H, Qi J, Lin S-Q, Zhang C-Y, Liu F, Xie W-D, et al. STAT3 targets ERR-α to promote epithelial–mesenchymal transition, migration, and invasion in triple-negative breast cancer cells. Mol Cancer Res. 2019;17:2184–95.
Chen Y, Zhang K, Li Y, He Q. Estrogen-related receptor α participates transforming growth factor-β (TGF-β) induced epithelial-mesenchymal transition of osteosarcoma cells. Cell Adh Migr. 2016;11:338–46.
Huang X, Wang X, Shang J, Zhaang Z, Cui B, Lin Y, et al. Estrogen related receptor alpha triggers the migration and invasion of endometrial cancer cells via up regulation of TGFB1. Cell Adh Migr. 2018;12:538–47.
Luo J, Sladek R, Carrier J, Bader J-A, Richard D, Giguere V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol. 2003;23:7947–56.
Villena JA, Hock MB, Chang WY, Barcas JE, Giguère V, Kralli A. Orphan nuclear receptor estrogen-related receptor α is essential for adaptive thermogenesis. Proc Natl Acad Sci USA. 2007;104:1418–23.
Cui H, Lu Y, Khan MZ, Anderson RM, McDaniel L, Wilson HE, et al. Behavioral disturbances in estrogen-related receptor alpha-null mice. Cell Rep. 2015;11:344–50.
De Jesús-Cortés H, Lu Y, Anderson RM, Khan MZ, Nath V, McDaniel L, et al. Loss of estrogen-related receptor alpha disrupts ventral-striatal synaptic function in female mice. Neuroscience. 2016;329:66–73.
Stein RA, Chang C, Kazmin DA, Way J, Schroeder T, Wergin M, et al. Estrogen-related receptor α is critical for the growth of estrogen receptor–negative breast cancer. Cancer Res. 2008;68:8805–12.
Deblois G, Hall JA, Perry M-C, Laganiere J, Ghahremani M, Park M, et al. Genome-wide identification of direct target genes implicates estrogen-related receptor as a determinant of breast cancer heterogeneity. Cancer Res. 2009;69:6149–57.
Deblois G, Chahrour G, Perry M-C, Sylvain-Drolet G, Muller WJ, Giguère V. Transcriptional control of the ERBB2 amplicon by ERRα and PGC-1β promotes mammary gland tumorigenesis. Cancer Res. 2010;70:10277–87.
Yu G, Lin J, Liu C, Hou K, Liang M, Shi B. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis. Sci Rep. 2017;7. https://doi.org/10.1038/s41598-017-16781-9.
Avena P, De Luca A, Chimento A, Nocito MC, Sculco S, La Padula D, et al. Estrogen related receptor alpha (ERRα) a bridge between metabolism and adrenocortical cancer progression. Cancers. 2022;14:3885.
Cerutti C, Zhang L, Tribollet V, Shi J-R, Brillet R, Gillet B, et al. Computational identification of new potential transcriptional partners of ERRα in breast cancer cells: specific partners for specific targets. Sci Rep. 2022;12:3826.
Cerutti C, Shi J-R, Vanacker J-M. Multifaceted transcriptional network of estrogen-related receptor alpha in health and disease. Int J Mol Sci. 2023;24:4265.
Auld KL, Berasi SP, Liu Y, Cain M, Zhang Y, Huard C, et al. Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling. J Mol Endocrinol. 2012;48:177–91.
Berman AY, Manna S, Schwartz NS, Katz YE, Sun Y, Behrmann CA, et al. ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism. Sig Transduct Target Ther. 2017;2:17035.
Chaveroux C, Eichner LJ, Dufour CR, Shatnawi A, Khoutorsky A, Bourque G, et al. Molecular and genetic crosstalks between mTOR and ERRα Are key determinants of rapamycin-induced nonalcoholic fatty liver. Cell Metab. 2013;17:586–98.
Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, et al. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis. Nat Cell Biol. 2016;18:645–56.
Valcarcel-Jimenez L, Macchia A, Crosas-Molist E, Schaub-Clerigué A, Camacho L, Martín-Martín N, et al. PGC1α suppresses prostate cancer cell invasion through ERRα transcriptional control. Cancer Res. 2019;79:6153–65.
Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, et al. ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors. Oncogene. 2019;38:950–64.
Tribollet V, Barenton B, Kroiss A, Vincent S, Zhang L, Forcet C, et al. miR-135a inhibits the invasion of cancer cells via suppression of ERRα. PLoS ONE. 2016;11:e0156445.
Han L, Liu B, Jiang L, Liu J, Han S. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha. Tumor Biol. 2016;37:13205–14.
Tribollet V, Cerutti C, Géloën A, Berger E, De Mets R, Balland M, et al. ERRα coordinates actin and focal adhesion dynamics. Cancer Gene Ther. 2022;29:1429–38.
Acknowledgements
Work in our laboratories is funded by Ligue contre le Cancer (comités Rhône, Ardèche and Drôme), ANSES (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, grant EST15-076), JoRiss/ENS research program and Région Auvergne-Rhône-Alpes (grant SCUSI OPE2017_004). The authors thank Violaine Tribollet for helpful discussions.
Author information
Authors and Affiliations
Contributions
CF drafted the manuscript and prepare the figures. JMV provide critical feedbacks and contributed to the revisions of the manuscript. JMV and CF approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vanacker, JM., Forcet, C. ERRα: unraveling its role as a key player in cell migration. Oncogene 43, 379–387 (2024). https://doi.org/10.1038/s41388-023-02899-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-023-02899-w